CIK 0001676725 · Large accelerated filer
IDEAYA Biosciences, Inc.
Sign in to watch- Ticker
- IDYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474268251
- Phone
- 650-443-6209
- Business address
- 5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $985,397
- in 1 filing, $985K under 10b5-1 plans
Net −$985,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 67 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-30 | Ruiz Briseno Andres See Remarks | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2025-11-28 | Snyder Douglas B. SVP, General Counsel | Grant or award | +1,041 | $16.91 | $18K | 2,080 |
| 2025-11-28 | Ruiz Briseno Andres See Remarks | Grant or award | +1,253 | $16.91 | $21K | 26,466 |
| 2025-06-24 | YARNO WENDY L Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-06-24 | Stein Jeffrey Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-06-24 | Hampton Malcolm Garret Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-06-24 | Morrison Scott W Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-06-24 | MACKEY CATHERINE J Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-06-24 | ROSEN TERRY J Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-05-30 | Snyder Douglas B. SVP, General Counsel | Grant or award | +1,039 | $16.91 | $18K | 1,039 |
| 2025-02-27 | Beaupre Darrin Chief Medical Officer | Grant or award · Stock Option (right to buy) | +185,000 | 185,000 | ||
| 2025-02-27 | DORMAN STUART Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2025-02-27 | Ruiz Briseno Andres See Remarks | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2025-02-27 | WHITE MICHAEL ANTHONY Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +185,000 | 185,000 | ||
| 2025-02-27 | Snyder Douglas B. SVP, General Counsel | Grant or award · Stock Option (right to buy) | +33,000 | 33,000 | ||
| 2025-02-27 | Hata Yujiro S President and CEO | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2025-02-18 | Hata Yujiro S President and CEO | Option exercise | +12,808 | $19.52 | $250K | 690,695 |
| 2025-02-18 | Hata Yujiro S President and CEO | Option exercise · Stock Option (right to buy) | −12,808 | 182,192 | ||
| 2024-11-29 | Ruiz Briseno Andres See Remarks | Grant or award | +682 | $23.26 | $16K | 25,213 |
| 2024-09-26 | Snyder Douglas B. SVP, General Counsel | Grant or award · Stock Option (Right to Buy) | +140,000 | 140,000 |
Page 2 of 10 · 186 trades